Format

Send to

Choose Destination
Heart Fail Clin. 2008 Jan;4(1):23-36. doi: 10.1016/j.hfc.2007.10.001.

Ventricular-vascular interaction in heart failure.

Author information

1
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA. borlaug.barry@mayo.edu

Abstract

Nearly half of all patients who have heart failure have preserved ejection fraction (HFpEF). Patients who have HFpEF tend to be older, female, and hypertensive, and characteristically display increased ventricular and arterial stiffening. In this article, we discuss the pathophysiology of abnormal ventriculoarterial stiffening and how it affects ventricular function, cardiovascular hemodynamics, reserve capacity, and symptoms. We conclude by exploring how novel treatment strategies targeting abnormal ventricular-arterial interaction might prove useful in the treatment of patients who have HFpEF.

Republished in

PMID:
18313622
PMCID:
PMC2586173
DOI:
10.1016/j.hfc.2007.10.001
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center